Cargando…
Anticancer properties and pharmaceutical applications of ginsenoside compound K: A review
Ginsenoside compound K (CK) is the major intestinal bacterial metabolite of ginsenosides that exhibits anticancer potential in various cancer cells both in vitro and in vivo. The anticancer types, mechanisms, and effects of CK in the past decade have been summarized in this review. Briefly, CK exert...
Autores principales: | Zhou, Li, Li, Zhong‐Kun, Li, Cong‐Yuan, Liang, Yue‐Qin, Yang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541358/ https://www.ncbi.nlm.nih.gov/pubmed/34793617 http://dx.doi.org/10.1111/cbdd.13983 |
Ejemplares similares
-
A narrative review of the pharmacology of ginsenoside compound K
por: Liu, Tao, et al.
Publicado: (2022) -
Genome-scale CRISPR screening for potential targets of ginsenoside compound K
por: Yang, Yuanyuan, et al.
Publicado: (2020) -
Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
por: Wang, Li, et al.
Publicado: (2022) -
Ginsenoside compound K alleviates osteoarthritis by inhibiting NLRP3‑mediated pyroptosis
por: Li, Yuguo, et al.
Publicado: (2023) -
Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis
por: Li, Ling, et al.
Publicado: (2018)